SDHB and paraganglioma: Accordingly, human HEK293 cells treated with siRNA against the SDH component SDHB showed increased susceptibility to the LDH inhibitor oxamate, suggesting LDH as a potential target in paraganglioma therapy (Bancos et al.2013).